Figure 3 illustrates how ATP1B3 had a particular stimulating influence on the malignant development of gliomas and how high expression of the protein was positively connected with patients’ bad prognoses. This is consistent with the results of current studies (17–19), which preliminarily confirms that ATP1B3 is an oncogene and is associated with poor prognosis. This evidence concerns the gene ATP1B3 and central nervous system cancer.